Kognitiv Recognized in 2023 TMW 100 List of Most Innovative Companies in Marketing Technology

TORONTO, Sept. 18, 2023 /CNW/ – Kognitiv is thrilled to announce that it has earned a spot on…

BlueRock’s Phase I study with bemdaneprocel in patients with Parkinson’s disease meets primary endpoint

Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12…